The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
Abstract
Both blood vessels and nerves are guided to their target. Vascular endothelial growth factor (VEGF)A is a key signal in the induction of vessel growth (a process termed angiogenesis). Though initial studies, now a decade ago, indicated that VEGF is an endothelial cell‐specific factor, more recent findings revealed that VEGF also has direct effects on neural cells. Genetic studies showed that mice with reduced VEGF levels develop adult‐onset motor neuron degeneration, reminiscent of the human neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Additional genetic studies confirmed that VEGF is a modifier of motor neuron degeneration in humans and in SOD1 G93A mice—a model of ALS. Reduced VEGF levels may promote motor neuron degeneration by limiting neural tissue perfusion and VEGF‐dependent neuroprotection. VEGF also affects neuron death after acute spinal cord or cerebral ischemia, and has also been implicated in other neurological disorders such as diabetic and ischemic neuropathy, nerve regeneration, Parkinson's disease, Alzheimer's disease and multiple sclerosis. These findings have raised growing interest in assessing the therapeutic potential of VEGF for neurodegenerative disorders. BioEssays 26:943–954, 2004. © 2004 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Self-citationTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1326 · Cited by 3,078
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Self-citationVascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097565 · Cited by 1,389
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 2×
“cerebral ischemia enhances angiogenesis in the penumbra and improves neural recovery.((86)) Therefore, VEGF may have”
BackgroundVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,204
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Ferrara, N. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1358 · Cited by 1,085
Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,062
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995) · Circulation Research · doi:10.1161/01.res.77.3.638 · Cited by 1,040
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Self-citationRetrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
VEGF is necessary for exercise‐induced adult hippocampal neurogenesis
Fabel, K., Fabel, K., Tam, B., Kaufer, D., Baiker, A., Simmons, N., Kuo, C. J., & Palmer, T. D. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03041.x · Cited by 861
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 860
Self-citationRole of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 773
Self-citationSondell, M., Lundborg, G., & Kanje, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05731.1999 · Cited by 750 · cited 2×
“axonal outgrowth and promotes the survival of neurons and satellite cells,((14)) whereas inhibition of VEGFR-2 signaling blocks axonal outgrowth in response to VEGF.”
BackgroundKendall, R. L., Wang, G., & Thomas, K. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1355 · Cited by 724
Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia
Jin, K. L., Mao, X. O., & Greenberg, D. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10242 · Cited by 684
Marti, H. J. H., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E., & Risau, W. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64964-4 · Cited by 680
Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR
Levy, N. S., Chung, S., Furneaux, H., & Levy, A. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6417 · Cited by 663
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia
Levy, A. P., Levy, N. S., & Goldberg, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2746 · Cited by 629
Stein, I., Itin, A., Einat, P., Skaliter, R., Grossman, Z., & Keshet, E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3112 · Cited by 498
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482
van Bruggen, N., Thibodeaux, H., Palmer, J. T., Lee, W. P., Fu, L., Cairns, B., Tumas, D., Gerlai, R., Williams, S.-P., Campagne, M. V. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8218 · Cited by 457
Dal Canto, M. C., & Gurney, M. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00063-v · Cited by 435
Lino, M. M., Schneider, C., & Caroni, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04825.2002 · Cited by 424
Zhang, Z. G., Zhang, L., Tsang, W., Soltanian-Zadeh, H., Morris, D., Zhang, R., Goussev, A., Powers, C., Yeich, T., & Chopp, M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00002 · Cited by 402
The role of the 5′ untranslated region of an mRNA in translation regulation during development
van der Velden, A. W., & Thomas, A. A. M. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00134-4 · Cited by 381
Sondell, M., Sundler, F., & Kanje, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01326.x · Cited by 370
Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 369
Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H., Rudnicki, S. A., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1621 · Cited by 361
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360
Neufeld, G. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00140-2 · Cited by 350
Miller, R. G., Petajan, J. H., Bryan, W. W., Armon, C., Barohn, R. J., Goodpasture, J. C., Hoagland, R. J., Parry, G. J., Ross, M. A., Stromatt, S. C., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390215 · Cited by 345
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H. J., Dobbins, T., et al. (1998) · Neurology · doi:10.1212/wnl.51.2.583 · Cited by 340
Heath, P. R., & Shaw, P. J. (2002) · Muscle & Nerve · doi:10.1002/mus.10186 · Cited by 336
Hiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., & Shibuya, M. (2001) · PubMed · Cited by 330
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
Hayashi, T., Abe, K., Suzuki, H., & Itoyama, Y. (1997) · Stroke · doi:10.1161/01.str.28.10.2039 · Cited by 309
Hayashi, T., Abe, K., & Itoyama, Y. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199808000-00009 · Cited by 304
Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302
VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy
HOBSON, M. I., GREEN, C. J., & TERENGHI, G. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19740591.x · Cited by 297
Huez, I., Créancier, L., Audigier, S., Gensac, M.-C., Prats, A.-C., & Prats, H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6178 · Cited by 297
Wick, A., Wick, W., Waltenberger, J., Weller, M., Dichgans, J., & Schulz, J. B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06401.2002 · Cited by 283
Developmental Control of Blood Cell Migration by the Drosophila VEGF Pathway
Cho, N. K., Keyes, L., Johnson, E., Heller, J., Ryner, L., Karim, F., & Krasnow, M. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00676-1 · Cited by 276
Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N., & Tohyama, M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0495fje · Cited by 271
Ogunshola, O. O., Antic, A., Donoghue, M. J., Fan, S.-Y., Kim, H., Stewart, W. B., Madri, J. A., & Ment, L. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111085200 · Cited by 268
Boyd, J. G., & Gordon, T. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01891.x · Cited by 259
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, M., Alroy, J., Adelman, L. S., Weinberg, D. H., Ropper, A. H., et al. (2000) · Nature Medicine · doi:10.1038/74664 · Cited by 248
Small Vessel Disease and Alzheimer’s Dementia: Pathological Considerations
Kalaria, R. N. (2002) · Cerebrovascular Diseases · doi:10.1159/000049150 · Cited by 245
Widenfalk, J., Lipson, A., Jubran, M., Hofstetter, C., Ebendal, T., Cao, Y., & Olson, L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00399-3 · Cited by 236
Plate, K. H., Beck, H., Danner, S., Allegrini, P. R., & Wiessner, C. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00010 · Cited by 236
Familial amyotrophic lateral sclerosis
Hand, C. K., & Rouleau, G. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10001 · Cited by 235
Lennmyr, F., Ata, K. A., Funa, K., Olsson, Y., & Terént, A. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199809000-00009 · Cited by 233
Silverman, W. F., Krum, J. M., Mani, N., & Rosenstein, J. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00540-5 · Cited by 232
Buijs, P. C., Krabbe-Hartkamp, M. J., Bakker, C. J., de Lange, E. E., Ramos, L. M., Breteler, M. M., & Mali, W. P. (1998) · Radiology · doi:10.1148/radiology.209.3.9844657 · Cited by 221
Yasuhara, T., Shingo, T., Kobayashi, K., Takeuchi, A., Yano, A., Muraoka, K., Matsui, T., Miyoshi, Y., Hamada, H., & Date, I. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03254.x · Cited by 217
Benefit of valproic acid in suppressing disease progression of ALS model mice
Sugai, F., Yamamoto, Y., Miyaguchi, K., Zhou, Z., Sumi, H., Hamasaki, T., Goto, M., & Sakoda, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03765.x · Cited by 214
VEGF is a chemoattractant for FGF-2–stimulated neural progenitors
Zhang, H., Vutskits, L., Pepper, M. S., & Kiss, J. Z. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200308040 · Cited by 200
Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia
Kalaria, R. N., Cohen, D. L., Premkumar, D. R. D., Nag, S., LaManna, J. C., & Lust, W. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00190-9 · Cited by 192
Sondell, M., Lundborg, G., & Kanje, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02056-9 · Cited by 191
Sopher, B. L., Thomas, P. S., LaFevre-Bernt, M. A., Holm, I. E., Wilke, S. A., Ware, C. B., Jin, L.-W., Libby, R. T., Ellerby, L. M., & La Spada, A. R. (2004) · Neuron · doi:10.1016/s0896-6273(04)00082-0 · Cited by 191
Krum, J. M., Mani, N., & Rosenstein, J. M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00615-7 · Cited by 185
Acsadi, G., Anguelov, R. A., Yang, H., Toth, G., Thomas, R., Jani, A., Wang, Y., Ianakova, E., Mohammad, S., Lewis, R. A., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402753812458 · Cited by 181
Yonghua, Z., Kunlin, J., Ou Mao, X., & Greenberg, D. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0515com · Cited by 180
Identification of a Human VPF/VEGF 3′ Untranslated Region Mediating Hypoxia-induced mRNA Stability
Claffey, K. P., Shih, S.-C., Mullen, A., Dziennis, S., Cusick, J. L., Abrams, K. R., Lee, S. W., & Detmar, M. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.2.469 · Cited by 177
Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells
Forstreuter, F., Lucius, R., & Mentlein, R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00315-6 · Cited by 177
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
RG, M., JD, M., M, L., & DH, M. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310002601 · Cited by 159
Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor
Jin, K., Mao, X., Parmentier‐Batteur, S., McEachron, E., Leahy, A. A., & Greenberg, D. A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00154-3 · Cited by 155
Expression of vascular endothelial growth factor and its receptors in rat neural stem cells
Maurer, M. H., Tripps, W. K. C., Feldmann, R., & Kuschinsky, W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00407-5 · Cited by 154
Lang-Lazdunski, L., Matsushita, K., Hirt, L., Waeber, C., Vonsattel, J., & Moskowitz, M. A. (2000) · Stroke · doi:10.1161/01.str.31.1.208 · Cited by 151
Li, B., Xu, W., Luo, C., Gozal, D., & Liu, R. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00025-1 · Cited by 143
Krum, J. M., & Khaibullina, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00039-6 · Cited by 135
Huez, I., Bornes, S., Bresson, D., Créancier, L., & Prats, H. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0738 · Cited by 131
Svensson, B., Peters, M., König, H., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Kögel, D., & Prehn, J. H. M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000037988.07114.98 · Cited by 131
Facchiano, F., Fernandez, E., Mancarella, S., Maira, G., Miscusi, M., D’Arcangelo, D., Cimino-Reale, G., Falchetti, M. L., Capogrossi, M. C., & Pallini, R. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.1.0161 · Cited by 121
Simovic, D., Isner, J. M., Ropper, A. H., Pieczek, A., & Weinberg, D. H. (2001) · Archives of Neurology · doi:10.1001/archneur.58.5.761 · Cited by 118
Vascular Endothelial Growth Factor Rescues HN33 Neural Cells from Death Induced by Serum Withdrawal
Jin, K. L., Mao, X., & Greenberg, D. A. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:3:197 · Cited by 116
Samii, A., Unger, J. W., & Lange, W. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00064-6 · Cited by 116
Neurodegeneration: a failure of neuroregeneration?
Armstrong, R. J. E., & Barker, R. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06260-2 · Cited by 114
Beck, H., Acker, T., Püschel, A. W., Fujisawa, H., Carmeliet, P., & Plate, K. H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.4.339 · Cited by 113
Self-citationSköld, M. K., Cullheim, S., Hammarberg, H., Piehl, F., Suneson, A., Lake, S., Sjögren, A., Walum, E., & Risling, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00263.x · Cited by 111
Macrophage-mediated corpse engulfment is required for normalDrosophilaCNS morphogenesis
Sears, H. C., Kennedy, C. J., & Garrity, P. (2003) · Development · doi:10.1242/dev.00586 · Cited by 92
Harrigan, M. R., Ennis, S. R., Sullivan, S. E., & Keep, R. F. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-002-1035-1 · Cited by 91
Can VEGF reverse diabetic neuropathy in human subjects?
Veves, A., & King, G. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13038 · Cited by 88 · cited 1×
“The latter changes then lead to reduced nerve conduction velocities, axonal loss, demyelination and nerve dysfunction.((94)) Samii”
BackgroundFocal reductions of cerebral blood flow in amyotrophic lateral sclerosis: A SPECT study
Waldemar, G., Vorstrup, S., Jensen, T. S., Johnsen, A., & Boysen, G. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90204-x · Cited by 86
VEGF165 Therapy Exacerbates Secondary Damage Following Spinal Cord Injury
Benton, R. L., & Whittemore, S. R. (2003) · Neurochemical Research · doi:10.1023/a:1026013106016 · Cited by 84
The vascular endothelial growth factor mRNA contains an internal ribosome entry site
Miller, D. L., Dibbens, J. A., Damert, A., Risau, W., Vadas, M. A., & Goodall, G. J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01025-4 · Cited by 84
Qiu, M., Zhang, R., & Sun, F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02110.x · Cited by 61
Ramer, M. S., Bradbury, E. J., Michael, G. J., Lever, I. J., & McMahon, S. B. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03012.x · Cited by 61
Pitzer, M. R., Sortwell, C. E., Daley, B. F., McGuire, S. O., Marchionini, D. M., Fleming, M. F., & Collier, T. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00100-6 · Cited by 61
Popovici, C., Isnardon, D., Birnbaum, D., & Roubin, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00595-5 · Cited by 59
VEGF gene transfer for diabetic neuropathy.
Isner, J., Ropper, A. H., & Hirst, K. (2001) · PubMed · Cited by 57
Vascular endothelial growth/permeability factor in spinal cord injury
Vaquero, J., Zurita, M., Oya, S., & Coca, S. (1999) · Journal of Neurosurgery Spine · doi:10.3171/spi.1999.90.2.0220 · Cited by 49
Xu, J., Zheng, P., Shen, D. H., Yang, S., Zhang, L. M., Huang, Y. L., & Sun, F. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00948-x · Cited by 44
Expression of angiogenic factors in rabbit spinal cord after transient ischaemia
Hayashi, K., Sakurai, Abe, Sadahiro, Tabayashi, & Itoyama (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00156.x · Cited by 35
Absence of mutations in the hypoxia response element of VEGF in ALS
Gros‐Louis, F., Laurent, S. B., Lopes, A. A. S., et al. (2003) · Muscle & Nerve · doi:10.1002/mus.10498 · Cited by 34
The effect of leukaemia inhibitory factor on SOD1 G93A murine amyotrophic lateral sclerosis
Feeney, S. J., Austin, L., Bennett, T. M., Kurek, J. B., Jean-François, M. J. B., Muldoon, C., & Byrne, E. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00217-5 · Cited by 29
Animal models for motor neuron disease.
Green, S. L., & Tolwani, R. J. (1999) · PubMed · Cited by 22
Ochiai-Kanai, R., Hasegawa, K., Takeuchi, Y., Yoshioka, H., & Sawada, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02020-x · Cited by 17
Local cerebral blood flow in motor neuron disease: correlation with clinical findings
Kobari, M., Obara, K., Watanabe, S., Dembo, T., & Fukuuchi, Y. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00151-7 · Cited by 15
Cited by
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Cerebral preconditioning and ischaemic tolerance
Gidday, J. M. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1927 · Cited by 751
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Warner-Schmidt, J. L., & Duman, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610282104 · Cited by 438
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Rigau, V., Morin, M., Rousset, M.-C., de Bock, F., Lebrun, A., Coubes, P., Picot, M.-C., Baldy-Moulinier, M., Bockaert, J., Crespel, A., et al. (2007) · Brain · doi:10.1093/brain/awm118 · Cited by 429
Neurobiological markers of exercise-related brain plasticity in older adults
Voss, M. W., Erickson, K. I., Prakash, R. S., Chaddock, L., Kim, J. S., Alves, H., Szabo, A., Phillips, S. M., Wójcicki, T. R., Mailey, E. L., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.021 · Cited by 418
Metadata
- Authors
- Storkebaum, E., Lambrechts, D., & Carmeliet, P.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2004-08-17
- Volume
- 26
- Issue
- 9
- Pages
- 943-954
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2063709616
- Cited by
- 507
- References
- 112
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
